Archives

A multicenter cohort describes Y96D as a KRAS G12C inhibitor resistance mechanism with direct therapeutic implications.

Independent benchmark of graph models for somatic variant interpretation, with public validation sets and error analysis.

Preprint describing single-cell trajectories associated with mutant ESR1 in hormone-sensitive breast cancer.